chr2-53808314-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_015701.5(ERLEC1):ā€‹c.895A>Gā€‹(p.Thr299Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.0000014 ( 0 hom. )

Consequence

ERLEC1
NM_015701.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.429
Variant links:
Genes affected
ERLEC1 (HGNC:25222): (endoplasmic reticulum lectin 1) This gene encodes a resident endoplasmic reticulum (ER) protein that functions in N-glycan recognition. This protein is thought to be involved in ER-associated degradation via its interaction with the membrane-associated ubiquitin ligase complex. It also functions as a regulator of multiple cellular stress-response pathways in a manner that promotes metastatic cell survival. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 21. [provided by RefSeq, Aug 2011]
ASB3 (HGNC:16013): (ankyrin repeat and SOCS box containing 3) The protein encoded by this gene is a member of the ankyrin repeat and SOCS box-containing (ASB) family of proteins. They contain ankyrin repeat sequence and SOCS box domain. The SOCS box serves to couple suppressor of cytokine signalling (SOCS) proteins and their binding partners with the elongin B and C complex, possibly targeting them for degradation. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03606692).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ERLEC1NM_015701.5 linkuse as main transcriptc.895A>G p.Thr299Ala missense_variant 9/14 ENST00000185150.9
GPR75-ASB3NM_001164165.2 linkuse as main transcriptc.102-42729T>C intron_variant
ERLEC1NM_001127397.3 linkuse as main transcriptc.895A>G p.Thr299Ala missense_variant 9/13
ERLEC1NM_001127398.3 linkuse as main transcriptc.880-900A>G intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ERLEC1ENST00000185150.9 linkuse as main transcriptc.895A>G p.Thr299Ala missense_variant 9/141 NM_015701.5 P3Q96DZ1-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.00000399
AC:
1
AN:
250728
Hom.:
0
AF XY:
0.00000738
AC XY:
1
AN XY:
135476
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000329
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461376
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
2
AN XY:
726954
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 02, 2023The c.895A>G (p.T299A) alteration is located in exon 9 (coding exon 9) of the ERLEC1 gene. This alteration results from a A to G substitution at nucleotide position 895, causing the threonine (T) at amino acid position 299 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
14
DANN
Benign
0.62
DEOGEN2
Benign
0.020
.;T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.57
T;T
M_CAP
Benign
0.0036
T
MetaRNN
Benign
0.036
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;L
MutationTaster
Benign
1.0
D;N;N
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.43
N;N
REVEL
Benign
0.030
Sift
Benign
0.77
T;T
Sift4G
Benign
0.76
T;T
Polyphen
0.0
.;B
Vest4
0.076
MutPred
0.20
Loss of loop (P = 0.0512);Loss of loop (P = 0.0512);
MVP
0.13
MPC
0.21
ClinPred
0.017
T
GERP RS
-0.73
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.019
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1055803384; hg19: chr2-54035451; API